Page last updated: 2024-11-01

nilutamide and Polycystic Ovary Syndrome

nilutamide has been researched along with Polycystic Ovary Syndrome in 1 studies

Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Couzinet, B1
Thomas, G1
Thalabard, JC1
Brailly, S1
Schaison, G1

Trials

1 trial available for nilutamide and Polycystic Ovary Syndrome

ArticleYear
Effects of a pure antiandrogen on gonadotropin secretion in normal women and in polycystic ovarian disease.
    Fertility and sterility, 1989, Volume: 52, Issue:1

    Topics: Adult; Androgen Antagonists; Female; Gonadal Steroid Hormones; Gonadotropins; Humans; Imidazoles; Im

1989